| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 21.820 | 23.516 | 13.395 | 9.008 | 2.861 | 337 | 8.705 | 4.877 | 3.639 | 885 |
| Total Income - EUR | 21.820 | 23.516 | 13.395 | 9.008 | 2.861 | 337 | 8.705 | 4.877 | 3.639 | 885 |
| Total Expenses - EUR | 8.634 | 7.392 | 7.099 | 6.707 | 2.618 | 178 | 400 | 235 | 229 | 247 |
| Gross Profit/Loss - EUR | 13.187 | 16.123 | 6.296 | 2.300 | 243 | 159 | 8.304 | 4.641 | 3.410 | 638 |
| Net Profit/Loss - EUR | 12.532 | 15.653 | 6.162 | 2.210 | 214 | 149 | 8.043 | 4.495 | 2.882 | 536 |
| Employees | 1 | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Profilaxia 2003 S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.518 | 1.842 | 1.172 | 523 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 17.730 | 15.313 | 5.668 | 8.453 | 5.288 | 5.348 | 8.706 | 7.791 | 8.124 | 4.468 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.475 | 4.564 | 2.971 | 3.400 | 4.259 | 4.180 | 4.142 | 4.207 | 4.101 | 4.119 |
| Cash | 14.254 | 10.750 | 2.697 | 5.053 | 1.029 | 1.168 | 4.565 | 3.584 | 4.023 | 350 |
| Shareholders Funds | 14.587 | 15.698 | 6.381 | 8.474 | 425 | 566 | 8.596 | 4.698 | 7.565 | 4.440 |
| Social Capital | 45 | 45 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 5.662 | 1.458 | 460 | 503 | 4.864 | 4.782 | 110 | 3.093 | 559 | 28 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Profilaxia 2003 S.r.l.